dc.contributor.author |
Turan, N |
|
dc.contributor.author |
Benekli, M |
|
dc.contributor.author |
Unal, OU |
|
dc.contributor.author |
Unek, IT |
|
dc.contributor.author |
Tastekin, D |
|
dc.contributor.author |
Dane, F |
|
dc.contributor.author |
Algin, E |
|
dc.contributor.author |
Ulger, S |
|
dc.contributor.author |
Eren, T |
|
dc.contributor.author |
Topcu, TO |
|
dc.contributor.author |
Turkmen, E |
|
dc.contributor.author |
Babacan, NA |
|
dc.contributor.author |
Tufan, G |
|
dc.contributor.author |
Urakci, Z |
|
dc.contributor.author |
Ustaalioglu, BO |
|
dc.contributor.author |
Uysal, OS |
|
dc.contributor.author |
Ercelep, OB |
|
dc.contributor.author |
Taskoylu, BY |
|
dc.contributor.author |
Aksoy, A |
|
dc.contributor.author |
Canhoroz, M |
|
dc.contributor.author |
Demirci, U |
|
dc.contributor.author |
Dogan, E |
|
dc.contributor.author |
Berk, V |
|
dc.contributor.author |
Balakan, O |
|
dc.contributor.author |
Ekinci, AS |
|
dc.contributor.author |
Uysal, M |
|
dc.contributor.author |
Petekkaya, I |
|
dc.contributor.author |
Ozturk, SC |
|
dc.contributor.author |
Tonyali, O |
|
dc.contributor.author |
Cetin, B |
|
dc.contributor.author |
Aldemir, MN |
|
dc.contributor.author |
Helvaci, K |
|
dc.contributor.author |
Ozdemir, N |
|
dc.contributor.author |
Oztop, I |
|
dc.contributor.author |
Coskun, U |
|
dc.contributor.author |
Uner, A |
|
dc.contributor.author |
Ozet, A |
|
dc.contributor.author |
Buyukberber, S |
|
dc.date.accessioned |
2022-10-13T11:46:44Z |
|
dc.date.available |
2022-10-13T11:46:44Z |
|
dc.date.issued |
2015 |
|
dc.identifier.uri |
http://hdl.handle.net/11616/79623 |
|
dc.description.abstract |
Background: We examined the impact of adjuvant modalities on resected pancreatic and periampullary adenocarcinoma (PAC). |
|
dc.description.abstract |
Methods: A total of 563 patients who were curatively resected for PAC were retrospectively analyzed between 2003 and 2013. |
|
dc.description.abstract |
Results: Of 563 patients, 472 received adjuvant chemotherapy (CT) alone, chemoradiotherapy (CRT) alone, and chemoradiotherapy plus chemotherapy (CRT-CT) were analyzed. Of the 472 patients, 231 were given CRT-CT, 26 were given CRT, and 215 were given CT. The median recurrence-free survival (RFS) and overall survival (OS) were 12 and 19 months, respectively. When CT and CRT-CT groups were compared, there was no significant difference with respect to both RFS and OS, and also there was no difference in RFS and OS among CRT-CT, CT and CRT groups. To further investigate the impact of radiation on subgroups, patients were stratified according to lymph node status and resection margins. In node-positive patients, both RFS and OS were significantly longer in CRT-CT than CT. In contrast, there was no significant difference between groups when patients with node-negative disease or patients with or without positive surgical margins were considered. |
|
dc.description.abstract |
Conclusions: Addition of radiation to CT has a survival benefit in patients with node-positive disease following pancreatic resection. |
|
dc.description.abstract |
C1 [Turan, Nedim; Babacan, Nalan Akgul] Cumhuriyet Univ, Fac Med, Dept Med Oncol, TR-58140 Sivas, Turkey. |
|
dc.description.abstract |
[Benekli, Mustafa; Algin, Efnan; Cetin, Bulent; Coskun, Ugur; Uner, Aytug; Ozet, Ahmet; Buyukberber, Suleyman] Gazi Univ, Fac Med, Dept Med Oncol, TR-06560 Ankara, Turkey. |
|
dc.description.abstract |
[Unal, Olcun Umit; Unek, Ilkay Tugba; Oztop, Ilhan] Dokuz Eylul Univ, Fac Med, Dept Med Oncol, TR-35340 Izmir, Turkey. |
|
dc.description.abstract |
[Tastekin, Didem] Necmettin Erbakan Univ, Fac Med, Dept Med Oncol, TR-42080 Konya, Turkey. |
|
dc.description.abstract |
[Dane, Faysal] Marmara Univ, Fac Med, Dept Med Oncol, TR-34000 Istanbul, Turkey. |
|
dc.description.abstract |
[Ulger, Sukran] Gazi Univ, Fac Med, Dept Radiat Oncol, TR-06560 Ankara, Turkey. |
|
dc.description.abstract |
[Eren, Tulay; Ozdemir, Nuriye] Numune Educ & Res Hosp, Dept Med Oncol, TR-06100 Ankara, Turkey. |
|
dc.description.abstract |
[Topcu, Turkan Ozturk] Karadeniz Tech Univ, Fac Med, Dept Med Oncol, TR-61000 Trabzon, Turkey. |
|
dc.description.abstract |
[Turkmen, Esma] Trakya Univ, Fac Med, Dept Med Oncol, TR-22020 Edirne, Turkey. |
|
dc.description.abstract |
[Tufan, Gulnihal] Rize Educ & Res Hosp, Dept Med Oncol, TR-53200 Rize, Turkey. |
|
dc.description.abstract |
[Urakci, Zuhat] Dicle Univ, Fac Med, Dept Med Oncol, TR-21280 Diyarbakir, Turkey. |
|
dc.description.abstract |
[Ustaalioglu, Basak Oven; Ercelep, Ozlem Balvan] Dr Lutfi Kirdar Kartal Educ & Res Hosp, Dept Med Oncol, TR-34668 Istanbul, Turkey. |
|
dc.description.abstract |
[Uysal, Ozlem Sonmez] Sakarya Educ & Res Hosp, Dept Med Oncol, TR-54050 Sakarya, Turkey. |
|
dc.description.abstract |
[Taskoylu, Burcu Yapar] Pamukkale Univ, Fac Med, Dept Med Oncol, TR-20070 Denizli, Turkey. |
|
dc.description.abstract |
[Aksoy, Asude] Inonu Univ, Fac Med, Dept Med Oncol, TR-44315 Malatya, Turkey. |
|
dc.description.abstract |
[Canhoroz, Mustafa] Firat Univ, Fac Med, Dept Med Oncol, TR-23200 Elazig, Turkey. |
|
dc.description.abstract |
[Demirci, Umut; Helvaci, Kaan] Dr Abdurrahman Yurtaslan Educ & Res Hosp, Dept Med Oncol, TR-06200 Ankara, Turkey. |
|
dc.description.abstract |
[Dogan, Erkan] Yuzuncu Yil Univ, Fac Med, Dept Med Oncol, TR-65080 Van, Turkey. |
|
dc.description.abstract |
[Berk, Veli] Erciyes Univ, Fac Med, Dept Med Oncol, TR-38000 Kayseri, Turkey. |
|
dc.description.abstract |
[Balakan, Ozan] SutcuImam Univ, Fac Med, Dept Med Oncol, TR-46100 Kahramanmaras, Turkey. |
|
dc.description.abstract |
[Ekinci, Ahmet Siyar] Diyarbakir Educ & Res Hosp, Dept Med Oncol, TR-21010 Diyarbakir, Turkey. |
|
dc.description.abstract |
[Uysal, Mukremin] Afyon Kocatepe Univ, Fac Med, Dept Med Oncol, TR-03200 Afyon, Turkey. |
|
dc.description.abstract |
[Petekkaya, Ibrahim] Dr Ersin Arslan State Hosp, Dept Med Oncol, TR-27010 Gaziantep, Turkey. |
|
dc.description.abstract |
[Ozturk, Selcuk Cemil] Adiyaman Univ, Educ & Res Hosp, Dept Med Oncol, TR-02040 Adiyaman, Turkey. |
|
dc.description.abstract |
[Tonyali, Onder] Mustafa Kemal Univ, Fac Med, Dept Med Oncol, TR-31070 Antakya, Turkey. |
|
dc.description.abstract |
[Aldemir, Mehmet Naci] Ataturk Univ, Fac Med, Dept Med Oncol, TR-25240 Erzurum, Turkey. |
|
dc.source |
CHINESE JOURNAL OF CANCER RESEARCH |
|
dc.title |
Impact of adjuvant treatment modalities on survival outcomes in |
|
dc.title |
curatively resected pancreatic and periampullary adenocarcinoma |
|